CSSB Centre for Structural Systems Biology
Suche
Home Research Research Groups Landau Group

Landau Group

Virulent & Antibacterial Amyloids

Prof. Meytal Landau

Associate member


meytal.landau@cssb-hamburg.de

Home Institute

Technion - Israel Institute of Technology
mlandau.net.technion.ac.il/

We investigate microbial amyloid fibrils, which serve as key “weapons” making infections more aggressive. In addition, we identify and explore peptides produced across kingdoms of life that provide antimicrobial protection and form amyloid fibrils. We seek to determine the high-resolution structures of these virulent and antimicrobial amyloids, to correlate the structure to specific functions, and elucidate the mechanisms underlining their regulation and activities.

Research Projects

PREVIOUS AND CURRENT RESEARCH

Self-assembly of proteins and peptides into amyloid fibrils occurs across all kingdoms of life. The phenomenon is notoriously associated with neurodegenerative and systemic diseases; however, amyloids also play critical roles during microbial infections both as host-derived antimicrobials and microbial virulence factors. The latter has rendered bacterial amyloids as attractive candidates for molecular and structural characterization aimed at understanding self-assembly and discovering novel therapie. In contrast to the vast body of knowledge on eukaryotic amyloids and dysbiosis during neurodegenerative diseases, high-resolution structures and molecular level characterization of the regulation, activity, mechanisms and interactions of microbial amyloids is lacking. The urgency in filling the knowledge gap between eukaryotic and bacterial amyloids has recently been exacerbated by paradigm-shifting Alzheimer’s disease research, including the antimicrobial protection hypothesis.

A novel cross-a amyloid form.
While human amyloids share cross-b features of tightly mated b-sheets, the Landau group discovered a novel amyloid form that is composed entirely of amphipathic α-helices that stack perpendicular to the fibril axis into mated cross-α ‘sheets’ (Fig. 1) (Tayeb-Fligelman et al., Science 2017; ref 1).  The cross-α fibril form was revealed by the crystal structure of the cytotoxic phenol-soluble modulin α3 (PSMα3) peptide secreted by the pathogenic Staphylococcus aureus bacterium. This also provided the first high resolution structure of a bacterial amyloid fibril. We showed that cross-α fibrillation facilitated PSMα3 cytotoxicity against human T2-cells. Extensive mutagenesis analyses suggested that PSMα3 cytotoxicity involves a dynamic process of co-aggregation with the cell membrane, and subsequent cell rupture [refs 1,2,6].

The cross-α fibril form was shown once more by the crystal structure of the uperin 3.5 antimicrobial peptide (AMP) secreted by Uperoleia mjobergii (Mjoberg's toadlet) (Salinas et al., PNAS 2021; ref 8). Surprisingly, uperin 3.5 showed a secondary structure switch between cross-a and cross-b fibrils, depending on environmental conditions. In particular, the presence of lipids which drive a transition to an α-helical state. Therefore, as evidence mounts to suggest that the diversity of fibril morphological space is correlated to activity and controlled by environmental cues, we need to expand the catalogue of amyloids structures.

The amyloid-antimicrobial link.
A potential physiological link between amyloid production in humans and resistance to microbial infections was previously suggested by Tanzi, Moir and others. The uperin 3.5 atomic resolution data revealed a link between a-helical amyloid fibrils and antimicrobial activities by showing the first known antimicrobial peptide with a capacity to form both cross-a and conventional cross-β amyloid fibrils. Altogether, these studies complement previous work on neurodegenerative-associated amyloids displaying antimicrobial activity.

FUTURE PROJECTS AND GOALS

Our findings and the advent of novel imaging techniques, including cutting-edge approaches of cryogenic electron light and correlative microscopy and tomography, now allow us to pose our ambitious overarching goal.

  • We aim to elucidate the specific relationships between membrane interaction, fibril formation, secondary-structure, morphology, and activities of virulent and antimicrobial amyloids.
  • A cross α/β switch regulation model will be evaluated via structural and biophysical studies, mutations and truncations, and visualization of the interactions with membrane mimetics and cells.
  • We aim to identify more general features that regulate the fibril secondary structure switch and its functional implications, and use this information for the design of novel antimicrobial agents.

SELECTED PUBLICATIONS

Tayeb-Fligelman E, Tabachnikov O, Moshe A, Goldshmidt-Tran O, Sawaya MR, Coquelle N, Colletier J-P, Landau M. (2017) The Cytotoxic Staphylococcus aureus PSMα3 Reveals a Cross-α Amyloid-like Fibril. Science 355(6327): 831-833

Malishev R, Tayeb-Fligelman E, David S, Meijler M, Landau M*, Jelinek R*. (2018) Reciprocal Interactions between Membrane Bilayers and S. aureus PSMalpha3 Cross-alpha Amyloid Fibrils Account for Species-Specific Cytotoxicity. J. Mol. Biol. 430(10):1431-1441 *Co-corresponding authors

Salinas N, Moshe A, Colletier J-P, Landau M. (2018) Extreme Amyloid Polymorphism in Staphylococcus aureus Virulent PSMα Peptides. Nat. Commun. 9(1):3512; 2018.

M. Landau. Mimicking Cross-α Amyloids. Nat. Chem. Biol. 14(9):833-834

Perov S, Lidor O, Salinas N, Golan N, Tayeb-Fligelman E, Deshmukh M, Willbold D, Landau M. (2019) Structural Insights into Curli CsgA Cross-β Fibril Architecture Inspired Repurposing of Anti-amyloid Compounds as Anti-biofilm Agents. PLoS Pathog 15(8): e1007978

Tayeb-Fligelman E, Salinas N, Tabachnikov O, Landau M. (2020) Staphylococcus aureus PSMα3 Cross-α Fibril Polymorphism and Determinants of Cytotoxicity. Structure S0969-2126(19)30445-9

Engelberg Y, Landau M. (2020) The Human LL-37(17-29) Antimicrobial Peptide Reveals a Functional Supramolecular Nanostructure. Nat. Commun. 11, 3894

Salinas N, Tayeb-Fligelman E, Sammito M, Bloch D, Jelinek R, Noy D, Uson I, Landau M. (2021) The Amphibian Antimicrobial Peptide Uperin 3.5 is a Cross-α/Cross-β Chameleon Functional Amyloid. PNAS 118 (3) e2014442118

Ragonis-Bachar P, Landau M. (2021) Functional and pathological amyloid structures in the eyes of 2020 cryo-EM. Curr Opin Struct Biol. 22;68:184-193; 2021

Engelberg Y, Ragonis-Bachar P, Landau M. (2022) Rare by Natural Selection: Disulfide-bonded Supramolecular Antimicrobial Peptides. Biomacromolecules 23, 3, 926–936 

Bücker R, Seuring C, Cazey C, Veith K, García-Alai M, Grünewald K, Landau M. The Cryo-EM Structures of two Amphibian Antimicrobial Cross-β Amyloid Fibrils.  Under ReviewBioRxiv